Mirna Therapeutics, Inc. Publishes Preclinical Data Demonstrating Therapeutic Effects of microRNA in Hematological Cancer  
5/2/2012 10:09:56 AM

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. announced today the publication of new results in the journal Leukemia demonstrating that the therapeutic delivery of microRNA-34 (miR-34) mimics inhibits tumor growth in an animal model of lymphoma.